References
- Shahidi H., Myers J. L., Kvale P. A. Subject review: Castleman's disease. Mayo Clink Proceedings. 1995; 70: 969–977
- Keller A. R., Hochholzer L., Castleman B. Hyaline‐vascular and plasma‐cell types of giant lymph node hyperplasia of die mediastinum and other locations. Cancer 1972; 29: 670–683
- Weisenburger D. D., Nathwani B. N., Winberg C. D., Rappaport H. Multicentric angiofollicular lymph node hyperplasia: a clinicopathologic study of 16 cases. Human Pathology 1985; 16: 162–172
- Frizzera G. Castleman's disease: more questions than answers. Human Pathology 1985; 16: 202–205
- Baruch Y., Ben‐Arie Y., Kerner H., Lorber M., Best L., Gershani‐Baruch R. Giant lymph node hyperplasia (Castleman's disease): a clinical study of eight patients. Postgraduate Medicine Journal 1990; 67: 366–70
- Soubrier M. J., Dubost J., Sauvezie B. POEMS Syndrome: A study of 25 cases and a review of the literature. American Journal of Medicine 1994; 97: 543–551
- Chetty R., Duhig J. Bilateral pheochromocytomaganglioneuroma of the adrenal in type I neurofibromatosis. American Journal of Surgical Pathology 1993; 17: 837–841
- Matsui I., Tanimura M., Kobayashi N., Sawada T., Nagahara N., Akatsuka J. Neurofibromatosis type I and childhood cancer. Cancer 1993; 72: 2746–2754
- Leger‐Ravet M. B., Peuchmaur M., Devergne O., Audouin J., Raphael M., Van Damme J., Galanaud P., Diebold J., Emilie D. Interleukin‐6 gene expression in Castleman's disease. Blood 1991; 78: 2923–2930
- Yoshizaki K., Matsuda T., Nishimoto N., Kuritani T., Taeho L., Aozasa K., Nakahata T., Kawai H., Tago H., Komori T., Kishimoto S., Hirano T., Kishimoto T. Pathogenic significance of interleukin‐6 (IL‐6/BSF‐2) in Castleman's disease. Blood 1989; 74: 1360–1367
- Brandt S. J., Bodine D. M., Dunbar C. E., Nienhuis A. W. Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice. Journal of Clinical Investigation 1990; 86: 592–599
- Beck J. T., Hsu S., Wijdenes J., Bataille R., Klein B., Vesole D., Hayden K., Jagannath S., Barlogie B. Brief report: alleviation of systemic manifestations of Castleman's disease by monoclonal anti‐interleukin‐6 antibody. New England Journal Of Medicine 1994; 330: 602–605
- Fukumoto S., Matsumoto T., Harada S., Fujisaki J., Kawano M., Ogata E. Pheochromocytoma with pyrexia and marked inflammatory signs: a paraneoplastic syndrome with possible relation to interleukin‐6 production. Journal of Clinical Endocrinology and Metabolism 1991; 73: 877–81
- Suzuki K., Miyashita A., Inoue Y., Iki S., Enomoto H., Takahashi Y., Takemura T. Interleukin‐6‐producing pheochromocytoma. Acta Haematologica 1991; 85: 217–219